SYNTA PHARMACEUTICALS CORP's ticker is SNTA and the CUSIP is 87162T206. A total of 84 filers reported holding SYNTA PHARMACEUTICALS CORP in Q3 2015. The put-call ratio across all filers is 1.53 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $15,000,000 | -31.8% | 61,223 | 0.0% | 0.00% | – |
| Q4 2015 | $22,000,000 | +20270.4% | 61,223 | -0.7% | 0.00% | – |
| Q3 2015 | $108,000 | -99.9% | 61,681 | +0.1% | 0.00% | -100.0% |
| Q2 2015 | $137,408,000 | -62.6% | 61,618 | -67.4% | 0.00% | -50.0% |
| Q1 2015 | $366,927,000 | -28.5% | 189,138 | -2.3% | 0.00% | 0.0% |
| Q4 2014 | $512,883,000 | -9.7% | 193,541 | +2.5% | 0.00% | -33.3% |
| Q3 2014 | $568,282,000 | -23.9% | 188,798 | +3.4% | 0.00% | 0.0% |
| Q2 2014 | $746,510,000 | +1.6% | 182,521 | +7.1% | 0.00% | 0.0% |
| Q1 2014 | $734,484,000 | +1.3% | 170,414 | +23.2% | 0.00% | 0.0% |
| Q4 2013 | $725,053,000 | +322.7% | 138,369 | +409.0% | 0.00% | +200.0% |
| Q3 2013 | $171,544,000 | +25.6% | 27,186 | -0.7% | 0.00% | 0.0% |
| Q2 2013 | $136,621,000 | – | 27,379 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 28,639,349 | $123,436,000 | 94.21% |
| Verity Asset Management, Inc. | 103,021 | $456,000 | 0.47% |
| NBW CAPITAL LLC | 242,153 | $1,044,000 | 0.27% |
| Old West Investment Management, LLC | 69,997 | $301,000 | 0.19% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 196,639 | $848,000 | 0.12% |
| SOPHROSYNE CAPITAL LLC | 25,700 | $111,000 | 0.10% |
| Cutler Capital Management, LLC | 45,000 | $194,000 | 0.08% |
| Rotella Capital Management, Inc. | 11,700 | $50,000 | 0.06% |
| STONERIDGE INVESTMENT PARTNERS LLC | 66,397 | $286,000 | 0.06% |
| Roundview Capital LLC | 21,100 | $91,000 | 0.04% |